FDA
-
-
-
-
-
-
-
Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Beta Bionics, Inc. (NASDAQ: BBNX); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The Simply Good Foods C
-
-
-
-
-
-
-
Beta Bionics prices $150M public offering of stock and warrants
-
-
-
-
-
-
-
Beta Bionics Announces FDA Clearance of Mint™, the Company’s Transformative Patch Pump, and Unveils 3D Intelligence™ as its Next-Generation Insulin Dosing Algorithm
-
-
-
-
-
-
-
Beta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in Development
-
-
-
-
-
-
-
Beta Bionics, Inc. (BBNX) PT Lowered to $22 at Stifel as 'Market Share Gains to Continue'
-
-
-
-
-
-
-
Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026
-
-
-
-
-
-
-
Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance
-
335,218 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


